Dr Neil Smith, primary care director at Lancashire and South Cumbria Cancer Alliance, said: "The earlier bowel cancer is spotted, the more treatable it’s likely to be, and nine in 10 people survive ...

All you need to know about the NHS Pension Scheme - how much you pay in, how the Scheme works, and what you can expect to get back. The NHS Pension Scheme is an attractive benefit for NHS employees.

and preclinical results from the Company's SMARCA2 monovalent direct degrader and CDK2 molecular glue degrader programs will be presented at the 2025 American Association for Cancer Research (AACR ...

As part of an NHS scheme aimed at eradicating cervical cancer by 2040, DIY smear tests for women could be introduced in England. The outgoing NHS England chief, Amanda Pritchard, detailed plans to ...

MILWAUKEE (CBS 58) -- As Colorectal Cancer Awareness Month comes to a close, health professionals and advocates say education efforts remain critical throughout the year. Gaulien Smith ...

By increasing equitable uptake of both HPV vaccination, which protects against most forms of the virus, and cervical screening, which checks for high-risk HPV, we can make cervical cancer a disease of ...

according to Cancer Research UK. Even more alarming is the charity's claim that the number of average cases per year could hit 47,700 by 2040. Article continues below To raise awareness, the NHS ...

today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...

Camilla Chapman was diagnosed with stage four stomach cancer almost a year after she ... She claimed there are no other options on the NHS available to her and she has been left feeling desperate ...

according to Cancer Research UK. The charity warns this figure could rise to 47,700 by 2040. In a bid to boost awareness, the NHS has underscored the critical importance of screening for the ...

today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...